Calcitonin gene-related peptide
peptide hormone in Homo sapiens
Calcitonin gene-related peptides (CGRP) are a group of two similar neuropeptides that belong to the calcitonin family. The two types of CGRP in humans are alpha-CGRP (α-CGRP, also known as CGRP I) and beta-CGRP (β-CGRP, also known as CGRP II). α-CGRP is a 37-amino acid neuropeptide formed by alternative splicing of the calcitonin/CGRP gene located on chromosome 11. β-CGRP is less studied. In humans, β-CGRP differs from α-CGRP by three amino acids and is encoded in a separate, nearby gene. The CGRP family includes calcitonin (CT), adrenomedullin (AM), and amylin (AMY).
Function
CGRP is produced in both peripheral and central neurons. It is a potent peptide vasodilator and can function in the transmission of nociception. In the spinal cord, the function and expression of CGRP may differ depending on the location of synthesis. CGRP is derived mainly from the cell bodies of motor neurons when synthesized in the ventral horn of the spinal cord and may contribute to the regeneration of nervous tissue after injury.
“Calcitonin gene-related peptide” enters the record as peptide hormone in Homo sapiens. Crown Archives preserves that source wording while asking what Calcitonin, gene-related and peptide can confirm, complicate or overturn.
Why this record matters
“Calcitonin gene-related peptide” is worth following because a concise public description often conceals a longer documentary argument. Here, Calcitonin, gene-related and peptide provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Sep 21, 2026. The linked authority identifier is Q419432. None of the 0 selected statements returned an explicit reference.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Calcitonin gene-related peptide”, its source revision and the description used here.
- Expand the search: follow Calcitonin gene-related peptide primary sources, Calcitonin gene-related peptide archive and Calcitonin research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Calcitonin gene-related peptide”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Calcitonin gene-related peptide” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.